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Foreword
Vishal Sharma1, Martin Stout2 and Keith Pearce2
1Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK
2Manchester Foundation Trust, Manchester, UK
Correspondence should be addressed to V Sharma: vishal.sharma@rlbuht.nhs.uk
The 2017 Annual Conference of the British Society of 
Echocardiography (BSE) was held in Edinburgh on the 
10th and 11th November. This was an extremely well-
supported conference with 751 delegates attending. 
We were delighted to offer an extremely high-quality 
educational programme. A particular highlight was the 
final session, which included the current presidents of the 
three major echocardiography societies in the world. Our 
own President, Mr Keith Pearce was joined by the President 
of the American Society of Echocardiography, Prof. Allan 
Klein and the President of the European Association of 
Cardiovascular Imaging, Prof. Bogdan Popescu.
This year’s BSE International Lecture was given by 
Prof. Klein, who gave a thorough overview of pericardial 
diseases and how to assess them with echo. The BSE Invited 
Lecture was delivered by Prof. John Simpson in which he 
gave us a glimpse into the future of echocardiography 
with his talk entitled ‘Frontiers in Congenital Heart 
Disease Imaging’. Prof. Bogdan Popescu also delivered an 
excellent talk on the assessment of atrial function as part 
of a dedicated session on the assessment of the left atrium.
For the first time the BSE also included a dedicated 
session devoted to patients. In the ‘My Echo’ session, patients 
gave their own unique perspectives of how their conditions 
have affected them and how echocardiography had 
directly impacted their lives. In one particularly memorable 
anecdote, one of the patients recounted how they had been 
admitted to hospital with significant breathlessness. Despite 
being treated for days for a chest infection, their condition 
steadily worsened and there were real concerns that they 
would not survive. They then described being taken into a 
darkened room for an ‘ultrasound scan’ that was undertaken 
by a cardiac physiologist. From that point on, the patient 
recounted that the course of their treatment and ultimately 
their life changed completely. Following the echo, their 
severe heart failure was diagnosed, they were moved to a 
cardiology ward, commenced on appropriate treatment and 
began to feel better. Their condition improved dramatically 
and over the next few weeks made an almost complete 
recovery. This important anecdote not only highlighted 
the impact that echocardiography has on patients but the 
importance of ensuring that it can be provided rapidly in all 
hospitals across the country.
A key theme for this conference was echocardiography 
in congenital heart disease and there was a dedicated 
congenital track running throughout the programme. 
Topics included detailed sessions on the sequential analysis 
of congenital heart disease with echocardiography, atrial 
and ventricular septal defects, right and left obstructive 
lesions and Tetralogy of Fallot. A particular highlight 
was the session on the assessment of atrial septal defect 
closure by Alex Savis and as a consequence we invited her 
and Prof. John Simpson to write a review on the topic for 
Echo Research and Practice (1).
We were also delighted to hear about the high-quality 
research that is happening across the United Kingdom at 
the conference and we have included the abstracts that 
were presented at the conference in this report.
As always we are grateful to all of our sponsors and 
industry partners without whom, the annual conference 
would not be possible.
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International Lecture 2017: Multimodality 
imaging in pericardial disease: an 
imaging-guided approach
Allan L Klein MD FRCP(C) FACC FAHA FESC
Center for the Diagnosis and Treatment of Pericardial Diseases, Department of Cardiovascular Medicine, Heart and Vascular Institute, Imaging, Cleveland 
Clinic, Cleveland, Ohio, USA
Pericardial diseases involve diseases of the sac that 
surrounds the heart. Compared to other cardiac diseases, 
there has been little interest in pericarditis since it has little 
effect on mortality. However, pericarditis can be associated 
with significant morbidity which has raised the interest in 
this field. In 2017, the new term ‘complicated pericarditis’ 
describes patients who have multiple recurrent episodes 
as well as constrictive pericarditis. Imaging modalities 
such as echo-Doppler, strain imaging and CMR/CT can 
help establish the diagnosis, prognosticate the severity as 
well as inform treatment.
The pericardium is composed of a serous layer including 
the visceral (epicardium) and parietal component as well 
as a fibrous layer. Viruses, uraemia, neoplasm and radiation 
can all damage the pericardial sac. Initially, there will be 
fibrinous exudates followed by neutrophil infiltration, 
neovascularization and then fibrosis. CMR with late 
gadolinium enhancement (LGE) has become an imaging 
biomarker of pericardial inflammation. Interestingly, LGE 
seems to relate to neovascularization of the pericardium 
and relates to the severity of the inflammation which 
portends a bad prognosis for having multiple recurrences 
and likely starting DMARDS and biologics.
Pericardial syndromes include acute, recurrent, 
incessant and chronic pericarditis, pericardial effusions/
tamponade, constrictive pericarditis and effusive 
constrictive pericarditis, pericardial masses, cysts and 
congenital absence of the pericardium. Recent ASE and ESC 
guidelines have defined how these conditions are diagnosed 
clinically. Ancillary signs such as elevated inflammatory 
markers (WSR and CRP) and pericardial inflammation 
on advanced imaging may help with the diagnosis. It is 
estimated that 15–30% of patients with acute pericarditis 
will develop recurrent episodes of which 6% may show 
multiple recurrences while some will develop transient 
constrictive pericarditis (treated with anti-inflammatories) 
and some will develop calcific constrictive pericarditis. The 
aetiology of pericarditis is different depending whether 
in the Western world (viral or idiopathic) or developing 
world (TB). An emerging cause of pericarditis is traumatic 
or iatrogenic (perforation or delayed onset).
Multimodality imaging plays an integral part in the 
diagnosis and treatment of pericardial diseases. Echo is 
usually the first-line test followed by CMR/CT which 
are second line which are recommended in patients 
with technically poor echoes, assessing inflammation or 
evaluating calcium in the setting of previous open heart 
surgery. Recognition of the different stages of pericarditis 
from single recurrence to advanced constriction will 
inform when to use echo, strain imaging, CMR and 
CT. Recent understanding of the pathophysiology of 
recurrent pericarditis suggests that there is activation of 
the ‘inflammasome’ of the cell, which may cause release of 
inflammatory biomarkers markers such as interleukins. This 
may be especially important due to the use of newer targeted 
therapies such as Il1 alpha and beta receptor blockers.
In conclusion, assessment of pericardial diseases using 
an imaging-guided approach is responsible for the new 
renaissance in pericardial diseases.
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Abstract 1: Left ventricular twist mechanics 
in hypertensive patients with preserved left 
ventricular ejection fraction and its relation 
to left atrial phasic function
Maryam Alsharqi MSc1,2 and Petros Nihoyannopoulos MD FRCP FESC FACC FAHA1
1Imperial College London, NHLI, Hammersmith Hospital, London, UK
2Department of Cardiac Technology, College of Applied Medical Sciences, Imam Abdulrahman Bin Faisal University, Dammam, Kingdom of Saudi Arabia
Aims
To evaluate the relation between left ventricular (LV) 
twist mechanics and left atrial (LA) phasic function 
in patients with systemic hypertension using speckle 
tracking echocardiography (STE). We hypothesised that 
the impairment of LA function is directly related to the 
reduction in LV untwisting rate (UTR) in hypertensive 
patients with preserved LV ejection fraction (EF).
Methods
In this prospective study, 74 hypertensive patients 
(54.17 ± 16.37 years) with preserved EF (65.7 ± 7.29%) were 
enrolled and compared with 20 normotensive controls. 
Basal and apical parasternal short axis views were used 
to assess LV twist mechanics, and apical four- and two-
chamber views were used to evaluate LA phasic function. 
Using EchoPac GE STE software, LV twist, UTR, and time 
to peak UTR were measured and LA longitudinal strain 
was obtained.
Results
Hypertensive patients with preserved LV EF showed 
reduced early diastolic UTR (P = 0.0001), prolonged time to 
peak UTR (P < 0.0001), impaired LA reservoir (P < 0.0001) 
and conduit (P < 0.0001) function when compared 
with controls. The reduction of LV UTR was positively 
correlated with the impairment of LA reservoir (r = 0.54, 
P < 0.0001) and conduit (r = 0.65, P < 0.0001) function.
Conclusion
In hypertensive patients with preserved LV EF (>50%), 
the impairment of LA reservoir and conduit function was 
correlated positively with the reduction in LV UTR, and 
inversely with time to peak UTR. These correlations may 
contribute toward the impairment of LV relaxation in 
hypertensive patients. LV twisting and LA strain indices 
by STE enable early detection of diastolic abnormalities 
even in the presence of normal findings in conventional 
2D echocardiography.
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Abstract 2: Feasibility, safety and accuracy of 
physiologist-led stress echocardiography for 
the detection of coronary artery disease
Jamal Nasir Khan MBChB PhD BMedSci MRCP1, Timothy Griffiths BA BSc PGDip Card2, Kully Sandhu DM MRCP2, 
Sinead  Cabezon MBChB2, Chun Shing Kwok MBBS MSc BSc MRCP2, Shanat Baig MBBS MRCP2, 
Tamara Naneishvili MBBS MRCP2, Vetton Chee Kay Lee MBChB2, Arron Pasricha MBChB2, Emily Robins MBChB2, 
Prathap Kanagala MBBS PhD MRCP3, Tamseel Fatima MBBS MRCP2, Andreea Mihai MBBS MRCP2, 
Robert Butler MBChB MD FRCP FACC2,  Simon Duckett MBBS MD BSc MRCP2 and Grant Heatlie MBBS PhD BSc MRCP2
1Department of Cardiology, University Hospital of Coventry & Warwickshire, Coventry, UK
2Department of Cardiology, University Hospital of North Midlands, Stoke-on-Trent, UK
3Department of Cardiology, Aintree Hospital, Liverpool, UK
Background
Physiologist-led stress echocardiography (PLSE) services 
provide potential for expansion of SE services and increased 
productivity for cardiologists. There is only one published 
study on PLSE and no studies assessing its accuracy. We 
sought to assess the feasibility, safety and accuracy of PLSE 
and CLSE for coronary artery disease (CAD) assessment.
Methods
Retrospective analysis of 898 patients undergoing PLSE or 
CLSE for CAD assessment using exercise or dobutamine 
stress over 24  months. Sixteen-segment wall-motion 
scoring (WMS, WMSI) analysis was performed. Feasibility 
(stressor, image quality, proportion of completed studies), 
accuracy (agreement with imaging cardiologist analysis, 
sensitivity and specificity compared with invasive 
coronary angiography) and safety (complication rate) 
were compared for PLSE and CLSE.
Results
The majority of studies were CLSE (56.2%) and used 
dobutamine (68.7%). PLSE more commonly used exercise 
(69.2%). 96% of studies were successfully completed (>14 
diagnostic segments in 98%, P = 0.899 PLSE vs CLSE). 
Commencement of PLSE was associated with an increase 
in annual stress echocardiograms performed for CAD 
assessment. Complication rates were comparably very low 
for PLSE and CLSE (0.8 vs 1.8%, P = 0.187). There was 
excellent agreement between PLSE and CLSE WMS 
interpretation of 480 myocardial segments at rest (κ = 0.87) 
and stress (κ = 0.70) and WMSI (ICCs and Pearson’s r values all 
>0.90, zero Bland–Altman mean bias). Sensitivity, specificity 
and accuracy for detection of significant CAD (correct 
identification of artery with >70% stenosis on invasive 
angiography) was high and similar for PLSE (sensitivity: 
83% (95% CI: 62–104%), specificity 78% (95% CI: 61–95%), 
accuracy 80%) and CLSE (sensitivity: 70% (95% CI: 42–98%), 
specificity 77% (65–88%), accuracy 75%).
Conclusion
To our knowledge, this is the first study of the feasibility, 
safety and accuracy of PLSE. PLSE performed by well-
trained physiologists is feasible and safe in contemporary 
practice. PLSE and CLSE interpretation of stress 
echocardiography for CAD agree closely and show similar 
accuracy compared with invasive angiography.
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Abstract 3: First-phase ejection fraction as a 
link between early systolic dysfunction and 
impaired diastolic function
Haotian Gu PhD and Phil Chowienczyk FRCP
British Heart Foundation Centre of Research Excellence, King’s College London, London, UK
Background
Impaired shortening-deactivation of cardiac myocytes 
could sustain myocardial contraction, preserving ejection 
fraction at the expense of diastolic dysfunction.
Objective
To examine whether an impairment of early systolic 
ejection is associated with sustained myocardial 
contraction and diastolic dysfunction.
Methods
The relation between first-phase ejection fraction (EF1), 
the fraction of left ventricular volume ejected from the 
start of systole to the time of the first peak in LV pressure 
(corresponding to the time of maximal ventricular 
shortening) to duration of myocardial contraction 
and diastolic function was examined in patients with 
hypertension (n = 163) and varying degrees of diastolic 
dysfunction. LV systolic pressure was estimated by carotid 
tonometry; time-resolved LV cavity and wall volume were 
obtained by echocardiography with speckle wall-tracking. 
Measurements were repeated after nitroglycerin, a drug 
known to influence ventricular dynamics, in a sub-sample 
(n = 18) of patients.
Results
EF1 and time of onset of ventricular relaxation (TOR, 
as determined from the temporal pattern of myocardial 
wall stress) were strongly correlated (standardized 
regression coefficients – 0.34 and 0.34 respectively, 
each P < 0.001) with diastolic function as measured by 
the ratio of transmitral Doppler early filling velocity to 
tissue Doppler early diastolic mitral annular velocity 
(E/E′) irrespective of adjustment for age, sex, anti-
hypertensive treatment, measures of afterload and 





























































Endocardial volume curve (solid line) obtained by echo wall-tracking, 
central aortic pressure waveform (dotted line) obtained by carotid 
tonometry, together with ejection-phase myocardial wall stress (dashed 
line), computed from the central aortic systolic pressure waveform and 
instantaneous left ventricular dimensions in a normotensive subject. 
Myocardial wall stress starts to fall at the first peak of central aortic 
pressure (T1), coinciding with peak aortic flow and maximal rate of 
ventricular shortening. EF1 is percentage volume change between 
end-diastole and T1.
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decreased TOR and improved diastolic function (each 
P < 0.05) (Fig. 1 and Table 1).
Conclusion
Hypertensive patients with diastolic dysfunction exhibit 
reduced first-phase ejection fraction which may sustain 
myocardial contraction, preserving systolic ejection 
fraction at the expense of impaired diastolic function.
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Table 1 Multivariate analysis of relations between EF1 and E/E′, TOR and E/E′ and ED/ES MWS.
Covariate
EF1 TOR ED/ES MWS
β P value β P value β P value
Model 1 (Enter)
 Age (years) 0.085 0.453 0.067 0.544 0.085 0.474
 Gender −0.195 0.040 0.017 0.859 0.070 0.488
 BMI (kg/m2) 0.122 0.135 0.076 0.358 −0.125 0.159
 HR (bpm) 0.040 0.668 −0.078 0.407 0.117 0.236
 SBP (mmHg) 0.045 0.831 0.182 0.401 −0.063 0.786
 DBP (mmHg) −0.248 0.154 −0.109 0.540 0.122 0.527
 arPWV (m/s) 0.007 0.960 0.064 0.669 −0.170 0.274
 AV Peak Flow (m/s) 0.078 0.499 −0.112 0.343 −0.073 0.558
 EDV (mL) −0.036 0.730 −0.160 0.130 0.172 0.119
 LVMI (g/m2) −0.011 0.916 −0.143 0.191 −0.070 0.551
 T1 (ms) 0.207 0.040 0.195 0.059 0.053 0.630
 Anti-hypertensive 0.157 0.062 0.042 0.626 0.025 0.782
 LA volume (mL) −0.034 0.701 0.160 0.079 −0.094 0.339
 Reflection Index 0.018 0.835 0.012 0.890 −0.154 0.094
 E/E′ −0.337 0.001 0.343 0.001 −0.233 0.030
Model 2 (Stepwise)
 Gender −0.225 0.002 – – – –
 DBP (mmHg) −0.246 0.001 – – – –
 Anti-hypertensive 0.166 0.026 – – – –
 LA volume (mL) – – – – −0.161 0.045
 E/E′ −0.328 <0.001 0.384 <0.001 −0.341 <0.001
arPWV, aortic root pulse wave velocity; AV, aortic valve; BMI, body mass index; bmp, beats per minute; DBP, diastolic blood pressure; E/E′, ratio of mitral 
valve Doppler early flow (E wave velocity) to tissue Doppler mitral annulus movement (E′ wave velocity); EDV, end-diastolic volume; EF1, first-phase ejection 
fraction; HR, heart rate; LA, left atrium; LVMI, left ventricular mass index; MWS ED/ES, ratio of end-diastolic and end-systolic myocardial wall stress; SBP, 
systolic blood pressure; T1, time to first systolic peak on pressure waveform; TOR, time to onset of relaxation. 




https://erp.bioscientifica.com © 2019 The British Society of Echocardiography
Published by Bioscientifica Ltd
Downloaded from Bioscientifica.com at 02/10/2021 02:33:14PM
via free access




Abstract 4: Cardiovascular risk assessment 
should be performed in patients with 
incidental aortic sclerosis
Linda Arnold1, Sean Coffey2,3, Margaret Loudon MBCHB MRCP DPhil1, Jo Wilson1, Andrew Kennedy1, 
Saul G Myerson MD FRCP FESC1 and Bernard Prendergast4
1Department of Cardiology, John Radcliffe Hospital, Oxford, UK
2Kolling Institute of Medical Research, University of Sydney, Sydney, Australia
3Department of Cardiology, Royal North Shore Hospital, Sydney, Australia
4Department of Cardiology, St Thomas’ Hospital, London, UK
Background
Aortic sclerosis (ASc) is a frequent incidental finding 
during echocardiographic examination. ASc is associated 
with, and may be an independent risk factor for, the 
development of cardiovascular (CV) events.
Purpose
To determine whether the increased CV risk associated with 
ASc was predicted by standard risk stratification using the 
QRISK2 CV risk assessment tool (prediction of 10-year CV 
event rate) in a cohort of patients over the age of 65 years.
Methods
We evaluated subsets of participants (total n = 201: 135 
with ASc; 66 controls) recruited to a population valve 
disease screening study (OxVALVE Study) using a nested, 
quantitative case–control study approach.
The QRISK2 10-year risk score was calculated and 
analysed according to echocardiographic results. Data 
concerning patient medication were also collected.
Results
The average QRISK2 score was significantly higher in the 
ASc group compared to the non-ASc group (30.1 vs 23.8%, 
P = 0.0006). The ASc group was older by just under 3 years 
(72.5 years vs 69.6 years, P = 0.0001). Total cholesterol and 
HDL/cholesterol ratios were similar in the two groups. 
There was a non-significant trend towards higher systolic 
blood pressure (155 mmHg vs 150 mmHg, P = 0.068) and 
diabetes in the ASc group (12.6 vs 6.1%, P = 0.22). The 
study was not powered to determine whether ASc was 
an independent risk factor for cardiovascular disease. Of 
patients (n = 143) with a QRISK of >20%, only 56% were 
on statins, 34% on aspirin and 28% on ACE inhibitors.
Conclusion
We have confirmed that ASc is a marker for higher 
cardiovascular risk as assessed by the QRISK2 score. 
Therefore, the incidental finding of ASc should 
serve as a prompt to reassess cardiovascular risk and 
echocardiography reports could highlight this finding. 
Many patients with high cardiovascular risk in our study 
were not on appropriate primary prevention medication.
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Abstract 5: Use of plasma NT-proBNP in 
patients with raised left ventricular filling 
pressure: assessment of the open access 
heart failure service in a Scottish hospital
Alice M Jackson MBChB MRCP1 and Vera Lennie MD FESC FRCPEdin2
1University Hospital Crosshouse, Kilmarnock, Scotland
2University Hospital Ayr, Ayr, Scotland
Introduction
It is well known that up to half of patients hospitalised 
for heart failure have a normal left ventricular ejection 
fraction (LVEF). Identifying raised LV filling pressures 
(LVFP) in this cohort is important to guide management. 
Data regarding the use of NT-proBNP in this setting, and 
its correlation with diastolic dysfunction, are lacking.
Aims
 • Describe the relationship between NT-proBNP and 
LVFP.
 • Identify the proportion of patients with raised 
NT-proBNP but normal LVEF and LVFP.
 • Examine the correlation between NT-proBNP and 
markers of LV systolic and diastolic function, including 
global longitudinal peak systolic strain (GLPSS).
Methods
We performed a retrospective analysis of all patients 
referred to our open access heart failure service over 
9  months. For those with NT-proBNP >300 ng/L, we 
collected echocardiographic measurements of LV 
systolic and diastolic function, and valvular disease. 
Contemporary ASE/EACVI recommendations were used 
to estimate LVFP. GLPSS was calculated using speckle 
tracking (GE software).
Results
A total of 172 NT-proBNP measurements were performed 
during the study period. Forty-eight (28%) patients had 
levels >300 ng/L. Baseline characteristics are shown in 
Table  2. LVFP was raised in 38%. 72% of patients with 
raised LVFP had NT-proBNP levels >900 ng/L and 6% had 
NT-proBNP levels of 300–450 ng/L (Fig. 2). A third of the 
cohort had normal LVEF and LVFP. Of these, 31% (n = 5) 
had atrial fibrillation (AF). 23% (n = 11) of patients had 
no evidence of reduced LVEF, raised LVFP, or AF. Figure 3 
shows the correlation of NT proBNP with markers of LV 
systolic and diastolic function, including GLPSS.
-19-0056ID: 19-0056
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Table 2 Baseline characteristics (n = 48).
Parameter Value
Male sex, n (%) 26 (54)
Age ≥75 years, n (%) 27 (56)




Atrial fibrillation, n (%) 11 (23)
More than mild valvular disease, n (%) 8 (17)
LVEF <50%, n (%) 15 (31)
GLPSS (%) −14 ± 0.6




https://erp.bioscientifica.com © 2019 The British Society of Echocardiography This work is licensed under a Creative Commons 
Attribution-NonCommercial-NoDerivatives 4.0 
International License.
Published by Bioscientifica Ltdhttps://doi.org/10.1530/ERP-19-0056
Downloaded from Bioscientifica.com at 02/10/2021 02:33:14PM
via free access




Our study demonstrates a clear association between 
NT-proBNP level and LVFP. This becomes more robust 
as the level increases >900 ng/L. Left atrial volume 
appears to correlate with NT-proBNP and is of value in 
routine assessment of patients with breathlessness. Few 
patients with raised LVFP had NT-proBNP levels 


























Degree of NT-proBNP elevation according to LV filling pressure.
Figure 3
Correlation of NT-proBNP with markers of LV systolic and diastolic function.
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Abstract 6: A comparative analysis of British 
and American Society of Echocardiography 
recommendations for the assessment of left 
ventricular diastolic function
Peter Lee Luke MSc BSc1, Christopher James Eggett PhD BSc2, Loakim Spyridopoulos MD3 and 
Timothy Simon Irvine MBChB FRCP1
1Echocardiography Department, Freeman Hospital, Newcastle upon Tyne, UK
2School of Biomedical Sciences, Newcastle University, Newcastle upon Tyne, UK
3Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
Introduction
The echocardiographic assessment of left ventricular 
diastolic function (LVDF) remains challenging. At present 
there are two recognised guidelines provided by the 
British Society of Echocardiography (BSE) and American 
Society of Echocardiography/European Association of 
Cardiovascular Imaging (ASE/EACVI). However, to date, no 
direct comparison of these guidelines has been performed 
to establish whether they provide similar diastolic grading.
Methods
Three hundred and thirty-three patients in sinus rhythm 
were extracted from our echo database (McKesson 
Cardiology). Eighty-seven (26%) patients were excluded 
due to left bundle branch block (2.1%), no indexed left 
atrial volume (18.2%) and annular calcification (5.7%). 
For each patient, LVDF assessment was performed using 
both guidelines and the results compared. Chi-square, 
Spearman correlation and Kappa score statistical tests 
were used to evaluate the data at a level of P < 0.05.
Results
The most frequent outcome was unclassifiable LVDF with 
significantly more patients being labelled unclassified 
by BSE (ASE/EACVI 31.3% vs BSE 39.5%, P < 0.0001). 
Having excluded unclassifiable patients, no difference 
was observed between the two schemes (P = 0.422) with 
substantial agreement when differentiating between 
normal and abnormal diastolic function (k = 0.694, 
P < 0.0001). Where there was disagreement between the 
two guidelines, (i.e. normal LVDF by one and abnormal 
by the other), the degree of LVDF was never more than 
grade I. When grading subcategories were individually 
compared there was moderate agreement between the two 
guidelines (k = 0.581, P < 0.0001). A significant correlation 
was seen between LV impairment (r = 0.55, P < 0.0001), 
indexed LA volume (r = 0.41, P < 0.001) and E/e′ (r = 0.68, 
P < 0.0001) with both diastolic grading schemes.
Conclusion
In around one-third of patients it was not possible to 
grade LVDF by either guideline. For those patients where 
grading was possible, there was no significant difference 
between BSE and ASE/EACVI guidelines with substantial 
agreement between each scheme when diagnosing normal 
or abnormal diastolic function and moderate agreement 
when comparing each LVDF subcategory.
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Abstract 7: Safety of stress echocardiography: 
a large single-centre experience
Nashwah Ismail and Anita Macnab
University Hospital of South Manchester, Manchester, UK
Background
Stress echocardiography (SE) is a widely used diagnostic 
tool for ischaemic heart disease. However, this type of 
functional testing has inherent risks and there is limited 
contemporary data on complication rates. We therefore 
carried out an audit of complications in a high-volume 
UK stress echo laboratory.
Methods
This was a retrospective audit of all SEs carried out in 
our center over 8  years between 2009 and 2017. Both 
dobutamine SE (DSE) and exercise SE (ESE) were included. 
The DSE protocol used a maximum dose of 30 µg/kg/min 
of dobutamine with atropine and handgrip augmentation 
as required. For ESEs the Bruce protocol was used on the 
treadmill and the WHO25 protocol on the semi-supine 
bicycle. Trans-pulmonary contrast was used in 95% of 
patients having DSE and 70% of patients having ESE. 
All complications were recorded even if no therapeutic 
intervention was required by the operator other than 
termination of the test.
Results
11,803 SEs (9179 DSEs and 2624 ESEs) were performed 
during the study period. There were no deaths. A total of 
342 (0.03%) adverse events were recorded. Complication 
rates were ten-fold higher during DSE than ESE (332 during 
DSE (0.04%) vs 10 during ESE (0.004%)). Ventricular 
arrhythmias occurred in 39 patients, 6 persisted beyond 
test termination and required drugs and/or defibrillation 
(all DSE), supraventricular tachycardia in 56 (52 DSE), 
atrial fibrillation/flutter in 37 (34 DSE), hypotension in 
175 (174 DSE), heart block in 3 (2 DSE) and ST elevation 
infarction in 17 requiring emergency admission for 
revascularization (all DSE). Contrast reactions were 
recorded in 15 patients with 9 developing a rapid and 
serious haemodynamic disturbance.
Conclusion
Stress echo is a safe functional imaging test. ESE results 
in significantly fewer complications than DSE. Contrast 
reactions occur more frequently than that reported by the 
manufacturers.
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Abstract 8: Grading of mitral stenosis by 3D 
transthoracic echocardiography
Caroline Bleakley MB BCh BAO MRCP MD, Mehdi Eskandari MD FRACP, Omar Aldalati, Almira Whittaker, 
Marilou Huang and Mark Monaghan PhD FRCP FESC FBSE FACC
King’s College Hospital, London, UK
Background
In mitral stenosis (MS), measuring the mitral valve orifice 
area (MVOA) by 3D transthoracic echocardiography (TTE) 
offers an adjustable dataset that can be manipulated to more 
accurately align with the true MVOA in comparison to 2D 
TTE. We studied differences in MVOA measurements between 
2D and 3D methods, to determine if 3D echocardiography 
would result in the re-grading of severity in any cases.
Methods
This was a head-to-head comparison of the three most 
commonly used tools to grade mitral stenosis by orifice 
area. 3D measurements of the MVOA were performed 
prospectively in 42 consecutive patients with at least mild 
mitral stenosis (MS) by traditional 2D estimates (pressure 
half-time (PHT), 2D MVO). The 2D MVOA was measured 
by the operator who performed the TTE, the 3D MVOA 
was measured separately by a blinded operator.
Results
The majority of patients were female (36; 86%), average age 
54 (17) years. Mean and peak MV gradients were 9.4 (4) 
mmHg and 19 (6) mmHg, respectively. Mean 2D planimetry 
MVOA was 1.27 (0.40) cm2 and mean 3D planimetry 
MVOA = 1.14 (0.29) cm2 (P = 0.003). Mean PHT was 169 
(65) ms with a mean MVOA of 1.43 (0.43) cm2 by PHT 
estimation (P = 0.046 and P < 0.001 in comparison to 2D and 
3D planimetry methods, respectively). In comparison to 2D 
measures, 3D planimetry reclassified seven patients from 
mild-to-moderate MS and three patients from moderate 
to severe (Fig. 4). Overall, the differences between the two 
methods were significant (χ2, P < 0.001).
Conclusion
3D planimetry of the MVOA returns significantly 
smaller measurements, which in some cases results in 
the reclassification of the grade of stenosis. Routine use 
of 3D measurements may have significant impact on 
the management of patients with MS by suggesting an 
increased severity of disease.
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Chart depicting the numbers of patients assigned into each category of 
mitral stenosis by each of the methods of mitral valve orifice area 
assessment. PHT, pressure half time; 2D, 2D planimetry; 3D, 3D 
planimetry.
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Abstract 9: 2-Year event rates of patients 
discharged from rapid access chest pain clinic 
after normal stress echocardiogram
Thomas  J Turner, Conor Steele and Anita Macnab MBChB FRCP
University Hospital of South Manchester, Manchester, UK
Aims
It is known that a normal stress echocardiogram (SE) 
carries a very high negative predictive value (NPV). We 
sought to determine the prognostic value of a negative SE 
when investigating patients for suspected angina in the 
setting of a contemporary rapid access chest pain clinic.
Methods
Between 2013 and 2015, patients who were investigated 
with SE were identified from the clinic records. The type 
of SE the patient underwent, exercise (ESE) or dobutamine 
(DSE), was also recorded. Only those with normal resting 
echo and normal SE were followed up with a telephone 
survey in 2017. Major adverse cardiac events (MACE) in 
the 2 years post discharge were recorded. Medical records 
were searched for all hospital admissions and deaths.
Results
In the 2-year study period, 1815 patients attended the 
clinic. Of these, 802 were investigated with SE, with 446 
receiving a negative result. Out of these, 95 were not 
contactable, which left 351 patients (DSE = 147 vs ESE = 204) 
with follow-up data. Pre-test probability of angina was low 
in 171 (49%), medium in 102 (29%) and high in 78 (22%) 
patients. Death occurred in nine patients, with only one 
being attributed to a cardiac cause. Overall, four MACE 
occurred (three events requiring revascularisation and 
one cardiac death). The MACE rate was 1 (0.28%) in the 
first year and 3 (0.85%) for the second year post discharge. 
The 2-year NPV for cardiac events was 98.86%. There was 
no significant difference between patients who received 
DSE and ESE (1 event (0.7%) in DSE group vs 3 events 
(1.5%) in ESE group; P = 0.493).
Conclusion
Negative SE in patients confers a high NPV and thus 
indicates an excellent prognosis, even in a population 
with a high proportion of patients (51%) with a medium 
or high pre-test probability of angina.
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Abstract 10: Echocardiography request and 
result reviewing behaviour: an audit of local 
practice
Anna Barton, Alan C Cameron BSc MBChB PhD and Piotr Sonecki
Queen Elizabeth University Hospital, Glasgow, UK
Introduction
An echocardiogram result can be reviewed in several ways. 
Locally, a report is generated featuring detailed results and 
a summary report. Images are also available to review, 
predominantly in the hospital setting. We investigated 
how different staff groups reviewed the echocardiograms 
they had requested.
Methods
A survey concerning echocardiogram requests, and result-
reviewing behavior was circulated via email to medical 
and specialist nursing staff in Glasgow. All levels of 
medical, surgical, radiology, OBGYN, paediatric and GP 
trainees, and staff grades, GPs, consultants, and nurse 
specialists were included, totaling 2218 hospital staff and 
266 GP practices. Responses were collected from 15/7/16 
to 2/8/16.
Results
Cardiologists (n = 16) were compared against hospital non-
cardiology (n = 126) and GP staff (n = 122). Cardiologists 
requested 41.4 echocardiograms/practitioner/month, 
compared to 6.5 for hospital non-cardiology staff, and 
1.3 for GPs. 100% of cardiologists always reviewed a 
summary report, compared to 94% of hospital non-
cardiology staff and 93% of GPs, compared to 80%, 58% 
and 31% respectively for the detailed report, and 33%, 
8% and 1% for images. No cardiologists described never 
reviewing any results, compared to 4% of hospital non-
cardiology staff and 2% of GPs.
Conclusion
Almost all respondents review at least one aspect of an 
echo report; however, most review the summary report 
alone. Cardiologists request the most scans and are most 
likely to review all aspects of the report. GPs request the 
least and are least likely to review a detailed report. Non-
cardiology staff request the greatest proportion of all 
echocardiograms, and review a detailed report in >50% of 
cases. Non-cardiologists are unlikely to review images. It is 
reasonable for non-specialists not to review more detailed 
aspects of an echocardiogram; this emphasizes the need 
for any vital messages to be communicated to the referrer 
through the summary report to optimize the chance of 
being reviewed.
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Abstract 11: Effectiveness and safety of stress 
echocardiography for detection of stress 
inducible, reversible myocardial ischaemia in 
Sandwell and West Birmingham Hospitals 
NHS Trust (SWBH)
Gyee Vuei Phang MBChB MRCP, Christos Voukalis MD MRCP, Hwee Phen Teh MBChB and Stavros Apostolakis MD PhD
Sandwell and West Birmingham NHS Trust, Birmingham, UK
Aim
To assess whether stress echocardiography (SE) is safe and 
has satisfactory detection rate of ischaemia.
Methods
We performed a retrospective study of a total of 426 
patients who had SE within a period of 12  months 
(February 2015 to January 2016) for assessment of 
ischaemia. All patients were followed up for a mean 
period of 20  months. Collected data included mode of 
stressors, complications, management of the positive SE 
results and readmission of patients with chest pain with 
their subsequent management plan.
Results
418 individuals completed the test and 8 tests were 
inconclusive. 78.9% had treadmill and 21.1% had 
dobutamine infusion as stressors. 99% of patients had no 
complications post-test; one patient suffered ventricular 
tachycardia, one patient had non-ST elevation myocardial 
infarction, three patients experienced troponin-negative 
chest pain and one patient suffered from contrast allergy. 
No deaths were reported.
12.7% (55) had positive SE and 83.6% (363) had 
negative SE (Table  3). Of the 55 patients who had 
positive SE outcome, 51 patients underwent coronary 
angiogram and 56.5% (31) of them were diagnosed 
with flow-limiting coronary artery disease. Nineteen 
were managed with percutaneous coronary angioplasty, 
eight with coronary artery bypass graft and four 
conservatively (Table 4).
6.1% (22) of the negative SE group had readmission 
with chest pain and/or acute coronary syndrome and 
underwent coronary angiogram, but only eight patients 
required revascularisation. There was no significant 
statistical difference between the dobutamine vs treadmill 
for detection of the negative SE. In contrast, for the 
detection of true positives, dobutamine was superior to 
exercise (P value, 0.009).
From the results, SE in our department has a sensitivity 
of 80%, specificity of 95%, positive predictive value of 
-19-0056ID: 19-0056; 
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Table 3 Results of the stress echocardiography.
Condition positive- Flow limiting CAD Condition negative- Non-flow limiting CAD Total (number)
Positive SE 31 20 51
Negative SE 8 355 363
Total (number) 39 375 414
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61%, negative predictive value of 98% and accuracy of 
93% for detection of myocardial ischaemia.
Conclusion
SE is a safe imaging modality with very low complication 
rate and is also efficient with an outstanding negative 
predictive value.
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Table 4 Details of positive and negative stress echocardiography results.
Positive SE Negative SE
Flow limiting CAD 31 No re-admission following SE 341
Non-flow limiting CAD 20 Re-admission requiring angiogram with no flow limiting CAD 14
Angiogram not performed 2 Re-admission requiring revascularisation 8
Angiogram not done based on clinical grounds 2
Total 55 Total 363
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Abstract 12: Right ventricular free wall 
thickness measured by echocardiography vs 
cardiac magnetic resonance imaging
Chih Wong MRCP MD1, Matthew M Y Lee MBChB MRCP1,2 and Nicolas E R Goodfield MBChB1
1Glasgow Royal Infirmary, Glasgow, UK
2British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK
Background
The guidelines of the American Society of 
Echocardiography (ASE) on the assessment of the right 
heart recommends that fundamental imaging should be 
used to measure right ventricular (RV) free wall thickness 
when image quality permits to ‘avoid the increased 
structure thickness seen with secondary harmonic 
imaging’. However, no reference is provided. We could 
not find any data comparing RV free wall thickness 
measured by echocardiography vs. cardiac magnetic 
resonance imaging (CMR). We hypothesized that RV free 
wall thickness is overestimated by secondary harmonic 
imaging by echocardiography.
Purpose
To compare RV free wall thickness measured by 
echocardiography vs CMR.
Methods
Thirty near-consecutive patients who had both 
echocardiography and CMR performed in our center in 
the past 6  months were selected. RV free wall thickness 
was measured independently by C W and N E R G using 
echocardiography with secondary harmonic imaging; and 
by C W and M M Y L using CMR. Patients with significant 
RV hypertrophy (>1.0 cm) were excluded. The results 
were compared using the Bland–Altman Plot to measure 
agreement between them.
Results
Among the 30 patients, the mean difference between 
echocardiography and CMR was 0.29 cm (standard 
deviation 0.11). The mean difference is statistically 
different from zero suggesting the measurements between 




Bland–Altman Plot comparing RV free wall thickness 
(cm) measured by echocardiography vs CMR.
https://erp.bioscientifica.com © 2019 The British Society of Echocardiography This work is licensed under a Creative Commons 
Attribution-NonCommercial-NoDerivatives 4.0 
International License.
Published by Bioscientifica Ltdhttps://doi.org/10.1530/ERP-19-0056
Downloaded from Bioscientifica.com at 02/10/2021 02:33:14PM
via free access
C Wong et al. Echocardiography vs CMR for 
RV thickness
M206:4
Figure  5 illustrates the results using the Bland–
Altman Plot showing the mean difference of 0.29 cm 
(red line) with 95% confidence interval of 0.07 
to 0.50 cm (green lines). This confirms the lack of 
agreement between echocardiography and CMR, with 
discrepancies of up to 0.50 cm by echocardiography. 
This discrepancy is too large to accurately measure the 
RV free wall with a normal reference range of ≤0.5 cm.
Conclusion
Compared to CMR, RV free wall thickness is 
overestimated by echocardiography using secondary 
harmonic imaging. Fundamental imaging (as per 
ASE guidelines) should be used to measure RV free 
wall thickness.
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Abstract 13: The use of left ventricle global 
longitudinal strain in the septic patient
Emma Lane BSc, David Slessor MBBS FRCEM FFICM and Richard Crawley BSc BMBS FRCP
Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, Portsmouth, UK
Background
Sepsis-induced cardiomyopathy occurs in up to 14% of 
patients with sepsis, resulting in myocardial depression 
typically resolving after 7–10 days. Transthoracic 
echocardiographic (TTE) assessment of left ventricular 
ejection fraction (LVEF) is typically used to define 
sepsis-induced cardiomyopathy. Recent meta-analysis 
demonstrates that low LVEF was not associated with 
mortality in septic patients. Advanced echocardiographic 
techniques such as global longitudinal strain (GLS) have 
evolved for direct assessment of the myocardial function. 
This technique may be beneficial for the assessment of 
sepsis-induced cardiomyopathy.
Primary objective
In critically ill patients with sepsis and septic shock, does 
GLS compared with LVEF identify more patients with 
myocardial dysfunction?
Methods
Over a 4-month period, GLS and LVEF were performed 
retrospectively from standard study imaging, on patients 
admitted to the Intensive Care Unit with sepsis, as defined 
by Sepsis-3 Criteria. All images were performed on GE 
S70 machines by a British Society Echocardiography 
accredited sonographer.
Results
Thirteen patients met the inclusion criteria and had 
adequate imaging to measure LVEF and GLS. Three 
patients had a reduced LVEF, whereas nine patients had a 
reduced GLS. This was a statistically significant difference 
(P = 0.047). Of the four patients who had a preserved 
LVEF and normal GLS, one patient was on inotropes 
and one patient had cirrhosis which is associated with a 
hyperdynamic circulation.
Conclusion
Critically ill patients with sepsis were statistically 
significantly more likely to have low GLS compared with 
reduced LVEF. These data suggest that GLS in standard TTE 
could have value in the septic patient for early detection 
of LV dysfunction. With the use of advanced techniques, 
septic-induced cardiomyopathy may be more commonly 
diagnosed. It may help identify patients who are critically 
ill from sepsis and target treatment accordingly. Future 
studies should investigate whether a reduced GLS is 
associated with mortality.
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Abstract 14: Physiologist-led dobutamine 
stress echocardiography: a service review
Theodoros Ntoskas MD, Farhanda Ahmad PgDMU and Paul Woodmansey MD FRCP
New Cross Hospital, Wolverhampton, UK
7Background
The DSE service has traditionally been a consultant 
cardiologist led service. However, with increasing 
demand, the expansion of DSE indications and to cut 
waiting times, a cardiac physiologist managed DSE service 
is running in our tertiary hospital. We audited the reason 
for the study, complications, safety and reliability, and 
validity of physiologist-led DSE services.
Methods
Retrospective analysis of 333 patients undergoing stress 
echocardiography for inducible reversible ischemia, 
myocardial viability and valvular heart disease (VHD) over 
6 months. Patients’ case notes review after 18–24 months.
Results
92% of all cases (306) were performed by physiologists. 
In 305 studies dobutamine was used (Table  5). The 
overwhelming majority of the referrals were for coronary 
artery disease (CAD) assessment (285). In 238 cases 
the study was uncomplicated. 67 patients developed 
dobutamine-related side effects including arrhythmias, 
nausea, vomiting, dizziness, vasovagal episodes, chest 
pain and shortness of breath (Table 6). In only 16 out of 
67 cases did the complications listed above lead to early 
termination of the study (Table 7). In two cases, urgent 
review from the on-call cardiologist registrar was needed 
because of severe vasovagal reactions. Of the 285 studies 
for CAD assessment, 244 were negative for ischemia, 28 
were positive and 13 inconclusive (Table 8). Only 7 cases 
with negative DSE for ischemia were readmitted as an 
ACS or for unstable angina; in these cases an invasive 
coronary angiogram (CA) or another non-invasive 
functional test revealed CAD (a false-negative rate for 
CAD of 2.9%). 5 out of 28 cases, with echocardiogram 
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Table 7 DSEs terminated early.
Cause of early termination DSEs terminated early (n = 18)
Arrhythmia 5
Nausea, vomiting, dizziness 4
Vasovagal episodes 3
Severe SOB 3
Severe chest pain 1
Patient anxiety 1
Poor windows 1
SOB, Shortness of Breath.
Table 6 Dobutamine stress echocardiography safety 
outcomes.
Complications during DSE Physiologist-led DSE (n = 303)
No complications 236 (77.89%)
All arrhythmias 47 (15.51%)
Vasovagal episodes 8 (2.64%)
Nausea, vomiting, dizziness 7 (2.31%)
Severe shortness of breath 3 (0.99%)
Severe chest pain 1 (0.33%)
LVOT gradient increase 1 (0.33%)
DSE, Dobutamine stress echocardiogram; LVOT, left ventricle outflow tract.
6
Table 5 Reason for study.
Physiologist-led DSE 
(n = 305)





Dynamic LVOT gradient/HOCM 2 (0.66%)
DSE, Dobutamine stress echocardiogram.
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evidence of inducible ischemia have subsequently 
undergone a CA, which showed unobstructed coronary 
arteries.
Conclusion
In our hospital, the majority of DSE lists are led by 
physiologists. The above results demonstrate the reliability 
and safety of this practice, and provide potential for 
the expansion of physiologist led DSE services in other 
hospitals.
Declaration of interest
The authors declare that there is no conflict of interest that could be 
perceived as prejudicing the impartiality of this article.
Funding
This work did not receive any specific grant from any funding agency in the 
public, commercial or not-for-profit sector.
Received in final form 21 October 2019
Accepted 21 October 2019








https://erp.bioscientifica.com © 2020 The authors
Published by Bioscientifica Ltd
Downloaded from Bioscientifica.com at 02/10/2021 02:33:14PM
via free access




Abstract 15: Does RV-E/e′ correlate with other 
echocardiographic indices of right atrial 
pressure?
Andrew J Fletcher MSc, Shaun Robinson MSc and Bushra S Rana MBBS FRCP
Royal Papworth Hospital Foundation Trust, Cambridge, UK
Background
Inferior vena cava (IVC) size and collapsibility upon 
inspiration, plus right atrial (RA) size, are commonly 
assessed during transthoracic echocardiography and 
are recommended to guide estimation of right atrial 
pressure (RAP). The ratio of right ventricular (RV) early 
diastolic filling velocity (E) to early diastolic tricuspid 
annular tissue velocity (e′), called RV-E/e′, is a surrogate 
of RV filling pressure and is another echocardiographic 
parameter which can be used to estimate RAP. Studies of 
RV-E/e′ suggest that it is strongly and positively correlated 
with invasively measured RAP, but less is known about 
its relationship with other echocardiographic parameters 
used to estimate RAP.
Aim
We sought to determine whether RV-E/e′ is correlated 
with IVC size, IVC collapsibility upon inspiration 
or with RA size when assessed with transthoracic 
echocardiography.
Methods
Data were collected retrospectively in consecutive patients 
in whom RV E velocity, RV e′ velocity, RA volume indexed 
to body surface area, IVC size and IVC collapsibility 
were assessed using transthoracic echocardiography 
(inclusion criteria). Patients with inter-atrial/ventricular 
communication, previous heart transplantation or 
at least moderate tricuspid/pulmonary regurgitation 
(TR/PR) were excluded. Images were obtained using 
Philips IE33 ultrasound machines by British Society of 
Echocardiography accredited cardiac physiologists as part 
of routine clinical service. Statistical analysis of normality 
and correlation were undertaken using SPSS. Significance 
was assumed for P < 0.05.
Results
Data from 138 patients was collected. Three patients 
were excluded due to inter-atrial communication, 7 
for previous heart transplantation and 25 for at least 
moderate TR/PR. Hence 103 patient’s data were analysed. 
Demographic and clinical details are presented in 
Table  9. RV-E/e′ was not statistically significantly 
correlated with IVC size (r = −0.17, P = 0.088), IVC 
collapsibility (r = −0.06, P = 0.524) or with RA size 
(r = −0.13, P = 0.202).
Conclusion
RV-E/e′ does not correlate with other echocardiographic 
parameters commonly used to estimate RAP in patients 
with a variety of pathologies.
-19-0056ID: 19-0056
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Table 9 Demographic and clinical information (n = 103).
Parameter Subclass (if applicable) Number (%) or mean (±s.d.)
Sex Male 65 (63%)
Female 38 (37%)
Heart rate (bpm) 68 (±13, range: 40–100)
Blood pressure (mmHg) Systolic 137 (±21)
Diastolic 77 (±12)
Body surface area (m2) 1.94 (±0.22)
Rhythm Sinus 87 (84%)
Ventricular paced 6 (6%)
Atrial fibrillation/flutter 10 (10%)
RA size Normal 59 (57%)
Mildly dilated 26 (25%)
Moderately dilated 17 (17%)
Severely dilated 1 (1%)
Primary clinical diagnosis Valvular heart disease 23 (22%)
Pulmonary hypertension 19 (18%)
Ischaemic heart disease 15 (15%)
Cardiomyopathy 12 (12%)
None (with normal heart) 11 (11%)
Lung disease 5 (5%)





Adams Oliver 1 (1%)
Aortic aneurysm 1 (1%)
Hypertension 1 (1%)
Myotonic dystrophy 1 (1%)
Unexplained syncope 1 (1%)
Systemic sclerosis 1 (1%)
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Abstract 16: A time-course of right ventricular 
remodeling in response to pulmonary 
endarterectomy in patients with chronic 
thromboembolic pulmonary hypertension
Liam Batchelor BSc MSc and Shaun Robinson MSc
Royal Papworth Hospital Foundation Trust, Cambridge, UK
Introduction
Pulmonary endarterectomy (PEA) is a potentially curative 
procedure for chronic thromboembolic pulmonary 
hypertension (CTEPH). Currently, little echocardiographic 
data exists regarding anatomical and functional 
remodelling of the right ventricle (RV) post-PEA, and 
whether pre-surgical haemodynamics influence recovery.
Methods
Forty patients (n = 40) who underwent PEA surgery 
for CTEPH were retrospectively sampled in a reverse 
chronological methodology. Patients underwent 
transthoracic echocardiography pre-surgery, and 3 
and 12  months post surgery. Patients were categorised 
according to the presence (PH+) or absence (PH−) of PH 
post surgery (Tables 10 and 11).
-19-0056ID: 19-0056; 
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Table 10 Main anthropometric and physiological measures.
Parameter All patients (n = 40) PH− (n = 26) PH+ (n = 14)
Age (years) 59 ± 14 59 ± 14 58 ± 14
Height (m) 1.72 ± 0.10 1.70 ± 0.09 1.76 ± 0.10
Mass (kg) 83.7 ± 18.7 84.7 ± 18.4 81.8 ± 20.0
BSA (m2) 2.0 ± 0.2 2.0 ± 0.2 2.0 ± 0.3
Gender (male/female) 28/12 18/8 10/4
WHO functional class
 II 10 (25%) 8 (31%) 2 (14%)
 III 25 (62.5%) 15 (58%) 10 (72%)
 IV 5 (12.5%) 3 (11%) 2 (14%)
6MWD (m) 332 ± 116 332 ± 115 330 ± 123
Pre-assessment mPAP (mmHg) 43 ± 10 40 ± 9 50 ± 10a
Pre-surgery mPAP (mmHg) 49 ± 14 45 ± 13 58 ± 12a
Post-surgery mPAP (mmHg) 24 ± 7 21 ± 3 31 ± 6a
Pre-assessment PVR (dyn/s/cm-5) 635 ± 284 527 ± 208 850 ± 300a
aSignificant difference between groups (P < 0.01).




(n = 39)a PH− (n = 25)a PH+ (n = 14)
Different disease on each sideb
 Type I 0 0 0
 Type II 5 (13%) 3 (12%) 2 (14%)
 Type III 7 (18%) 3 (12%) 4 (29%)
Same disease on each sidec
 Bilateral Type I 6 (15%) 3 (12%) 3 (21%)
 Bilateral Type II 13 (33%) 11 (44%) 2 (14%)
 Bilateral Type III 8 (21%) 5 (20%) 3 (21%)
aDisease classification not available for one patient. bPatients were 
categorised with the highest disease type. cDisease types were similar on 
each side.
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Table 12 Echocardiographic measures for PH− and PH+ groups pre and post surgery.
Parameter
Pre surgery 3 months post surgery 12 months post surgery
PH− PH+ PH− PH+ PH− PH+
RV basal (cm) 4.5 ± 0.8 5.2 ± 0.9a 3.9 ± 0.7b 4.5 ± 0.9a 4.0 ± 0.5 4.6 ± 0.9a
RV mid (cm) 3.5 ± 0.7 4.4 ± 0.6c 3.0 ± 0.6b 3.3 ± 0.7d 3.0 ± 0.5b 3.3 ± 0.7d
RV long (cm) 7.6 ± 0.7 8.5 ± 1.2a 7.2 ± 0.8 7.9 ± 0.9a 7.4 ± 0.9 8.1 ± 1.1a
iRAA (cm2/m) 13.1 ± 5.5 17.1 ± 4.6 10.1 ± 3.0 12.7 ± 4.5 11.2 ± 3.5 12.8 ± 3.5
RV–RA (mmHg) 61 ± 24 68 ± 19 28 ± 12d 48 ± 24a 26 ± 10d 39 ± 17a,e
PAT (ms) 84 ± 16 72 ± 15 106 ± 20d 96 ± 25b 110 ± 17d 95 ± 18
EIs 1.3 ± 0.4 1.7 ± 0.7 1.0 ± 0.1d 1.2 ± 0.2c 1.0 ± 0.0d 1.2 ± 0.2c
EId 1.1 ± 0.1 1.3 ± 0.2c 1.0 ± 0.0d 1.1 ± 0.1d 1.0 ± 0.0d 1.1 ± 0.1a,d
aSignificant difference between groups (P < 0.05); bsignificant difference compared to pre-surgery (P < 0.05); csignificant difference between groups (P < 0.01); 
dsignificant difference compared to pre-surgery (P < 0.01); esignificant difference from 3 months post surgery to 12 months post surgery (P < 0.01).
Figure 6
TAPSE measures in PH− and PH+ groups pre- and post-PEA. ΔSig dif 
compared to pre surgery (P < 0.01).
Figure 7
RV S′ measures in PH− and PH+ groups pre- and post-surgery. §Sig dif 
compared to pre-surgery (P < 0.05).
Figure 8
FAC measures in PH− and PH+ groups pre- and post-surgery. §Sig dif 
compared to pre-surgery (P < 0.05). *Sig dif between groups (P < 0.05).
Figure 9
EDA measures in PH- and PH+ groups pre- and post-surgery. §Sig dif to 
pre-surgery (P < 0.05). †Sig dif between groups (P < 0.01). *Sig dif between 
groups (P < 0.05).
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Results
Fourteen PH+ (n = 14) and twenty-six PH− (n = 26) patients 
were included in analysis (Table  12). Longitudinal 
functional parameters (RV S′; tricuspid annular plane 
systolic excursion (TAPSE)) were reduced at 3 and 
12  months in the PH− group compared to pre surgery 
(Figs 6 and 7). Fractional area change (FAC) was significantly 
increased in the PH group at 12 months compared to pre 
surgery (29.1 ± 9.2 to 35.9 ± 8.1%) (P = 0.049) (Fig. 8). PH+ 
measures of RV systolic function (RV S′; TAPSE; FAC) did 
not significantly change compared to pre-PEA. RV end-
diastolic (EDA) (Fig.  9) and end-systolic (ESA) (Fig.  10) 
areas were significantly different between groups at all 
time-points (P < 0.05). After 12 months, PH-ESA remained 
significantly lower compared to pre surgery (16.5 ± 5.3 to 
12.6 ± 3.7 cm2) (P = 0.019). No significant changes in PH+ 
RV areas were present at 12 months compared to pre-PEA. 
Pre-surgery pulmonary vascular resistance (PVR) showed 
significant (P < 0.01), moderate correlations with changes 
in EDA (r = −0.540), ESA (r = −0.577), and right atrial area 
(r = −0.538) to 3 months post PEA (Fig. 11 and Table 13).
Conclusion
This study suggests longitudinal function remains reduced 
one-year post-PEA regardless of post-surgical PH status, 
with gradual PH recovery of radial function. Although 
both groups EDA and ESA reduced significantly within 
three-months, only PH ESA reductions from pre-surgery 
were sustained at 12  months. Future research should 
establish whether anatomical and functional differences 
post-PEA are associated with symptomatic outcomes.
Table 13 Inter- and intra-rater statistics.
Parameter
Inter-rater Intra-rater
ICC CI (95%) ICC CI (95%)
TAPSE 0.977 0.909–0.994 0.994 0.976–0.999
RV S′ 0.989 0.954–0.997 0.995 0.981–0.999
FAC 0.867 0.466–0.967 0.953 0.811–0.988
EDA 0.958 0.831–0.990 0.982 0.928–0.996
ESA 0.951 0.804–0.998 0.987 0.946–0.997
RV basal 0.834 0.331–0.959 0.993 0.971–0.998
RV mid 0.913 0.652–0.979 0.989 0.958–0.997
RV long 0.918 0.668–0.980 0.986 0.942–0.996
RAA 0.994 0.977–0.999 0.997 0.989–0.999
PAT 0.936 0.718–0.986 0.977 0.887–0.995
EIs 0.896 0.582–0.974 0.977 0.914–0.995
EId 0.928 0.710–0.982 0.972 0.886–0.993
Figure 10
ESA measures in PH− and PH+ groups pre- and post-surgery. ΔSig dif 
compared to pre-surgery (P < 0.01). §Sig dif to pre-surgery (P < 0.05). †Sig 
dif between groups (P < 0.01). *Sig dif between groups (P < 0.05).
Figure 11
RAA measures in PH− and PH+ groups pre- and post-surgery. §Sig dif 
compared to pre-surgery (P < 0.05). *Sig dif between groups (P < 0.05).
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Abstract 17: Assessment of left atrial size by 
echocardiography: applying clinical guidelines 
in health and disease
Brogan McAdam and Caroline J Coats
Golden Jubilee National Hospital, Glasgow, UK
Objective
Left atrium (LA) enlargement is an important predictor of 
cardiovascular morbidity and mortality. LA size is estimated 
by 2D echocardiography using several methods. We 
assessed if discrepancies between methods occurred more 
commonly in different types of heart disease. A secondary 
aim was to audit local adherence to BSE guidelines.
Methods
LA size was measured in 218 consecutive subjects who met 
the inclusion/exclusion criteria at our hospital between 
January and June 2015. Four groups were compared: 
1, normal (n = 66); 2, isolated aortic stenosis, AS (n = 49); 
3, isolated moderate/severe mitral regurgitation, MR 
(n = 50); and 4, severe left ventricular dysfunction, 
SLVSD (n = 53). LA size was assessed as recommended by 
BSE using LA antero-posterior diameter (APD) and LA 
volume (LAV) measured using (a) area-length (AL) and 
(b) Simpson’s biplane method. Severity categories were 
assigned according to BSE and EACVI/ASE guidelines.
Results
There was good correlation between the biplane AL and 
Simpsons LAV methods (r = 0.984, P < 0.001), although LAV 
was higher using the AL method (42.26 ± 28.81 mL/m2) 
compared with Simpsons (39.27 ± 26.68 mL/m2, P < 0.001). 
When the indexed LA diameter and LAV by AL method 
were assigned a BSE severity category 57% showed 




All groups with BSE normal range.
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method and 32% when applying the 2015 ASE/EACVI 
guidelines. Discrepancies were greatest in patients with 
MR and SLVSD and least in the normal group (72, 75, 18% 
respectively) (Fig. 12). 94% of clinical reports derived LAV 
from the monoplane AL method and only 3% reported 
severity category using APD.
Conclusion
The discrepancy between LA diameter and volume 
measurements is greatest in patients with LVSD and 
MR. If the BSE were to adopt the 2015 ASE/EACVI 
guidance and normal ranges, it may help standardise 
LAV measurement and avoid misclassification of LA size 
by physiologists.
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Abstract 18: Identifying pacemaker patients 
who may be eligible for a device upgrade as a 
result of the NICE TA314 guidance
Louise C Mayall BSc MRes MSc, Keith Pearce BSc and Niall G Campbell PhD MRCP
Manchester Foundation Trust, Manchester, UK
Background
There is increasing evidence to suggest that long-term 
right ventricular (RV) apical pacing is associated with 
adverse outcomes such as progressive left ventricular (LV) 
dysfunction, heart failure and a significantly increased 
risk of mortality. The NICE TA314 guidance recommends 
the implantation of cardiac resynchronisation therapy 
(CRT) for patients with LV systolic dysfunction and an 
associated LV ejection fraction of 35% or less in order to 
restore electrical and mechanical synchrony.
Aims
 • To identify the percentage of RV-paced patients who 
are eligible for an upgrade to CRT based on the NICE 
TA314 guidance.
 • To determine whether patients with high percentages 
of RV apical pacing were more likely to be eligible for 
an upgrade to CRT.
Methods
Patients who were attending pacemaker outpatient 
clinics underwent a pacemaker check, a resting 12-lead 
electrocardiogram, a symptom assessment and a 
transthoracic echocardiogram in order to assess their 
eligibility for an upgrade to CRT.
Results
There was no significant difference between the 
percentage of patients who were eligible for an upgrade in 
the <40% paced and the ≥40% paced groups (n = 45). 18% 
of patients were eligible for a device upgrade.
Conclusion
This study has identified patients who meet the NICE 
TA314 eligibility criteria, thus allowing the NHS to focus 
its resources where they will achieve the greatest benefit.
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Abstract 19: The effects of hand-grip exercise 
on cardiac function during bike stress 
echocardiography in healthy adults
Hannah Garnett PhD MSc BSc, Martin Stout PhD MSc BSc and Keith Pearce BSc
Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK
Background
Bike stress echocardiography (BSE) is routinely used as a 
non-invasive test for functional myocardial ischaemia in 
patients experiencing angina-like chest pain. Myocardial 
ischaemia is diagnosed when reduced coronary blood flow 
results in regional wall motion abnormalities, which can 
be quantified using strain analysis. In current practice, 
patients are asked to perform a hand-grip exercise when 
leg fatigue develops to help ensure they reach their target 
heart rate (THR).
Aims
This study aimed to identify whether there is a difference 
in cardiac workload or duration of a satisfactory test, 
following isotonic bike exercise and isometric hand-grip 
exercise (IHGE) in combination, compared to isotonic 
bike exercise alone in healthy adults.
Methods
A repeated-measures design was used in which healthy 
adult volunteers were exercised to 85% of their THR using 
isotonic bike exercise alone in one session and isotonic 
bike exercise in combination with an IHGE in another 
session. Echocardiographic images and blood pressure 
were recorded throughout exercise and recovery. Systolic 
global longitudinal strain (GLS) and ejection fraction (EF) 
were calculated from echocardiogram images to assess 
cardiac workload and volumes.
Results
There was no significant difference in the response of GLS 
(n = 20) or EF (n = 24) to isotonic bike exercise alone when 
compared to isotonic exercise with an IHGE. There was 
also no significant change in the time taken to reach peak 
exercise, or to recover to a heart rate <100 bpm between 
the two exercise protocols (n = 20).
Conclusion
The addition of a hand-grip exercise to isotonic bike 
exercise had no effect on the cardiac workload or 
duration of a satisfactory BSE in healthy adults. Further 
work is now warranted to investigate whether an IHGE 
can increase the number of participants achieving a 
satisfactory BSE in a patient population, and potentially 
improve the sensitivity of BSE in detecting coronary 
artery disease.
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